MONICA CHEN: Open Payments
NPI 1326767633 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329 in 14 payments from 8 companies in 2025. Trend: 2023 $788 · 2024 $863 · 2025 $329
Food & beverage: $329
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $94 |
| Caris MPI, Inc. | 2 | $56 |
| Adaptive Biotechnologies Corporation | 2 | $50 |
| Melinta Therapeutics, LLC | 2 | $43 |
| EMD Serono, Inc. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Agios Pharmaceuticals, Inc. | 1 | $19 |
| Tris Pharma Inc | 1 | $16 |
Products named: Xtandi, MI CANCER SEEK, clonoSEQ, Rezzayo, Padcev, SCEMBLIX, PYRUKYND, Dyanavel XR.
Industry payments across CA — which companies pay providers there.
